Insulet claims EOFlow copied patch-pump design in patent suit
Insulet filed the lawsuit as competitor Medtronic plans to buy EOFlow for $738 million.
Insulet claims EOFlow copied patch-pump design in patent suit Read More »
Insulet filed the lawsuit as competitor Medtronic plans to buy EOFlow for $738 million.
Insulet claims EOFlow copied patch-pump design in patent suit Read More »
Amazon began automatically applying manufacturer coupons for some drugs in March, and is now adding new discounts for diabetes-related products.
Amazon Pharmacy expands insulin manufacturer coupons Read More »
A whistleblower accused Medtronic of violating the False Claims Act by billing the government for unnecessary medical procedures.
Medtronic’s bid to dismiss heart device kickback claims fails, clearing case to advance Read More »
Propanc Biopharma, Inc. today announced that the Company will target the Peter Mac Cancer Center in Melbourne, Australia, as the site for the First-In-Human (FIH) study for PRP in patients with advanced solid tumors.
Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its HLA-LOH assay as a companion diagnostic (CDx) test.
FDA Grants Breakthrough Device Designation To Tempus’ HLA-LOH Companion Diagnostic Test Read More »
Medicus IT, a trailblazer in healthcare technology solutions, proudly announces the appointment of Emily Sorrick as Chief People Officer.
As the laboratory services giant continues its acquisition streak, hundreds of employees will be let go at the Boston-based academic health system.
Labcorp scoops up Tufts Medicine outreach lab, continuing buying spree Read More »
The Boston-based health system posted an improvement in revenue and operating income after it was placed on a financial improvement plan by the state last year.
Mass General Brigham posts positive operating margin in Q3 after high 2022 losses Read More »
Viseon Inc. Announces Commercial Rollout and Initial Clinical Use of the 4K MaxView ® System for Advanced Digital Visualization during Minimally Invasive Spine Surgery.
Enspire DBS Therapy, Inc., (Enspire) a clinical stage company developing an implantable neuromodulation therapy for post-stroke recovery, announced today the publication of the results of The EDEN trial (Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke), an early feasibility study led by Cleveland Clinic researchers, in Nature Medicine.